tiprankstipranks
Reckitt Benckiser Group (RBGLY)
OTHER OTC:RBGLY
Want to see RBGLY full AI Analyst Report?

Reckitt Benckiser Group (RBGLY) Price & Analysis

253 Followers

RBGLY Stock Chart & Stats

$13.20
$0.03(0.23%)
At close: 4:00 PM EDT
$13.20
$0.03(0.23%)

Bulls Say, Bears Say

Bulls Say
Emerging Markets GrowthSustained double-digit growth in China and strong emerging markets performance diversify revenue and support structurally higher growth than developed markets. This durable geographic mix provides a multi-year runway for volume, pricing power and margin expansion as developed-market headwinds persist.
Innovation And PremiumizationRepeated successful product launches and premium SKUs show the company can drive mix improvement and share gains. A capacity to commercialize innovations across markets supports sustainable pricing power, repeat purchase behavior and long-term margin resilience versus pure cost-driven growth.
Fuel For Growth Cost ProgramA multi-year fixed-cost reduction program structurally lowers the cost base and improves operational leverage. Delivering sustained fixed-cost savings increases earnings sensitivity to revenue, helps absorb commodity volatility, and supports free cash flow needed to service debt and fund shareholder returns.
Bears Say
Elevated LeverageMeaningful leverage reduces financial flexibility and increases vulnerability to cash-flow shocks or higher interest rates. With debt at scale, sustained free cash flow is required to de-lever; any sustained revenue or margin weakness would constrain capital allocation and heighten refinancing risk over the next 2–6 months.
Revenue And Cash-flow SoftnessA pattern of declining top line and falling free cash flow undermines the quality of earnings recovery and increases reliance on cost cuts for profit improvement. Persistently weaker cash generation limits the company's ability to shrink leverage, invest behind innovation, or sustain elevated shareholder returns.
Gross Margin Headwinds & Category WeaknessInput-cost-driven gross margin compression and persistent promo intensity in Household Care erode sustainable profitability. Structural margin recovery will require either lasting pricing power or permanent cost reductions; otherwise margin volatility will pressure cash flow and returns.

Reckitt Benckiser Group News

RBGLY FAQ

What was Reckitt Benckiser Group’s price range in the past 12 months?
Reckitt Benckiser Group lowest stock price was $11.97 and its highest was $17.61 in the past 12 months.
    What is Reckitt Benckiser Group’s market cap?
    Reckitt Benckiser Group’s market cap is $44.84B.
      When is Reckitt Benckiser Group’s upcoming earnings report date?
      Reckitt Benckiser Group’s upcoming earnings report date is Mar 03, 2027 which is in 211 days.
        How were Reckitt Benckiser Group’s earnings last quarter?
        Reckitt Benckiser Group released its earnings results on Jul 29, 2026. The company reported $0.269 earnings per share for the quarter, missing the consensus estimate of $0.381 by -$0.112.
          Is Reckitt Benckiser Group overvalued?
          According to Wall Street analysts Reckitt Benckiser Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Reckitt Benckiser Group pay dividends?
            Reckitt Benckiser Group pays a Semiannually dividend of $0.236 which represents an annual dividend yield of 6.52%. See more information on Reckitt Benckiser Group dividends here
              What is Reckitt Benckiser Group’s EPS estimate?
              Reckitt Benckiser Group’s EPS estimate is 0.51.
                How many shares outstanding does Reckitt Benckiser Group have?
                Reckitt Benckiser Group has 3,175,275,000 shares outstanding.
                  What happened to Reckitt Benckiser Group’s price movement after its last earnings report?
                  Reckitt Benckiser Group reported an EPS of $0.269 in its last earnings report, missing expectations of $0.381. Following the earnings report the stock price went up 4.31%.
                    Which hedge fund is a major shareholder of Reckitt Benckiser Group?
                    Currently, no hedge funds are holding shares in RBGLY
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      Reckitt Benckiser Group

                      Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.

                      Reckitt Benckiser Group (RBGLY) Earnings & Revenues

                      RBGLY Company Deck

                      RBGLY Earnings Call

                      Q2 2026
                      0:00 / 0:00
                      Earnings Call Sentiment|Positive
                      The call conveyed a constructive tone driven by clear Q2 acceleration, strong emerging market execution and successful innovation launches, supported by disciplined cost actions under the Fuel for Growth program and active shareholder returns. Material lowlights remain: the dilutive impact of the Essential Home divestment (pressuring EPS and operating profit), gross margin headwinds from higher input costs and commodity volatility, weakness in Household Care/Auto Dish and some developed-market softness. Management reiterated guidance and emphasized confidence in mitigation plans, leaving the narrative net positive but balanced by identifiable execution and macro risks.View all RBGLY earnings summaries
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Church & Dwight
                      Colgate-Palmolive
                      Kimberly Clark
                      Procter & Gamble
                      Unilever

                      Ownership Overview

                      0.01%<0.01%99.91%
                      Insiders
                      <0.01% Other Institutional Investors
                      99.91% Public Companies and
                      Individual Investors
                      Popular Stocks